By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


deCODE chemistry 

2501 Davey Road

Woodridge  Illinois  60517  U.S.A.
Phone: 630-783-4600 Fax: 630-783-4909


The integrated service offerings of deCODE chemistry and deCODE biostructures provide a unique and comprehensive approach to drug discovery and development outsourcing. deCODE biostructures services span from computer-aided design of expression-optimized synthetic gene constructs to protein expression and ligand bound co-crystal structure determination for purposes of structure based drug design. Capabilities of deCODE chemistry include lead discovery and optimization, development of scalable synthetic routes, custom synthesis of API and intermediates, cGMP production of materials for pre-clinical and clinical studies, and pre-formulation screening. The combined value is that deCODE provides a complete solution for discovering and developing optimized clinical candidates in a time efficient manner. Flexible business terms allow for tailored projects on a fee-for-service basis, or as part of a more substantial collaboration. deCODE’s facilities, located in Woodridge, IL and Bainbridge Island, WA, total over 150,000 sq ft. of multi-disciplinary laboratory space outfitted with state-of-the-art equipment and world-class scientists.

Last Updated: 08-01-2006

Key Statistics

Ownership: Subsidiary

Web Site: deCODE chemistry

Company News
deCODE chemistry And deCODE biostructures: Fragments of Life – Enhancing Efficiency in Drug Discovery 7/24/2009 10:26:46 AM
deCODE chemistry & deCODE biostructures and UCB, Inc. (UCBJF.PK) Announce a Collaboration to Discover and Develop Novel Anti-Inflammatory Drugs 2/9/2009 12:55:32 PM
deCODE chemistry Release: Structure of a New Antibiotic Drug Target Revealed 1/5/2009 2:37:28 PM
Families Of Spinal Muscular Atrophy, Invitrogen Corporation (IVGN), And deCODE biostructures And deCODE chemistry Release: Protein Linked to Spinal Muscular Atrophy Identified 10/9/2008 10:46:49 AM
Alex Kiselyov Joins deCODE biostructures as President; Lance Stewart Appointed President of deCODE biostructures 7/3/2007 5:42:37 PM
deCODE chemistry Initiates Chemical Development Collaboration with SGX Pharmaceuticals, Inc. (SGXP) 6/14/2007 2:56:00 PM
deCODE chemistry Expands Process Chemistry Relationship with Anacor Pharmaceuticals, Inc. 6/14/2007 2:54:44 PM
deCODE chemistry Initiates Chemical Development Collaboration with PolyMedix Inc. for Multiple Pre-clinical Candidates 6/13/2007 2:06:26 PM